Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5683034 | 0.96 | APP (0.55) | APPL3MBTL1ATMTDP1ASIC3 | |
| SCHEMBL18091340 | 0.92 | APP (0.50) | APPL3MBTL1ATMTDP1ASIC3 | |
| SCHEMBL1155420 | 0.88 | ESR1 (0.46) | APPL3MBTL1ATMTDP1ASIC3 | |
| SCHEMBL55761 | 0.87 | APP (0.67) | APPL3MBTL1ATMTDP1MAPT | |
| SCHEMBL29357652 | 0.87 | APP (0.67) | APPL3MBTL1ATMTDP1MAPT | |
| SCHEMBL1155254 | 0.86 | APP (0.44) | APPL3MBTL1ATMTDP1ASIC3 | |
| SCHEMBL28392347 | 0.85 | APP (0.52) | APPL3MBTL1ATMTDP1ASIC3 | |
| SCHEMBL8829831 | 0.84 | APP (0.46) | APPL3MBTL1ATMTDP1ASIC3 | |
| SCHEMBL429961 | 0.82 | APP (0.48) | APPL3MBTL1ATMTDP1ASIC3 | |
| SCHEMBL30459389 | 0.82 | APP (0.48) | APPL3MBTL1ATMTDP1ASIC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 995 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102332-A1 | NERVE AND TUMOR HOMING AGENTS AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| EP-4352449-B1 | PROJECTILE PAYLOAD FOR TRAINING AMMUNITION WITH MULTI-SPECTRAL OUTPUT | CYALUME TECH INC (US) | 2025-05-07 | — | — | EP | claimed |
| US-20250084452-A1 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF A STERILIZATION PROCESS AND METHODS OF USE | TERRAGENE LLC | 2025-03-13 | — | — | US | claimed |
| CN-119552047-A | Co-assembly method for improving chromophore energy transfer efficiency, co-assembly body and application | 西安交通大学 | 2025-03-04 | — | — | CN | claimed |
| CN-114021429-B | Energy storage optimal configuration method considering reliability cost | 南京工程学院 | 2024-11-29 | — | — | CN | claimed |
| EP-4352449-A2 | PROJECTILE PAYLOAD FOR TRAINING AMMUNITION WITH MULTI-SPECTRAL OUTPUT | Cyalume Technologies, Inc (US) | 2024-04-17 | — | — | EP | claimed |
| US-11940253-B2 | Projectile payload for training ammunition with multi-spectral output | CYALUME TECHNOLOGIES, INC. (US) | 2024-03-26 | — | — | US | claimed |
| WO-2023140886-A2 | PROJECTILE PAYLOAD FOR TRAINING AMMUNITION WITH MULTI-SPECTRAL OUTPUT | CYALUME TECHNOLOGIES, INC. (US) | 2023-07-27 | — | — | WO | claimed |
| US-20230194226-A1 | Projectile payload for training ammunition with multi-spectral output | PNC BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2023-06-22 | — | — | US | claimed |
| US-20230037660-A1 | METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS | Blaze Bioscience, Inc. | 2023-02-09 | — | — | US | claimed |
| US-5889141-A | DISSOLVING WITH PHOTOSENSITIZER IN SOLVENT; COATING ON SUBSTRATE; EXPOSURE FILM TO LIGHT THROUGH MASK | HITACHI CHEMICAL CO., LTD. (JP) | 1999-03-30 | — | — | US | claimed |
| US-5885745-A | PHOTOLITHOGRAPHIC DIELECTRIC FILM | HITACHI CHEMICAL CO., LTD. (JP) | 1999-03-23 | — | — | US | claimed |
| EP-0898735-A1 | HOLOGRAPHIC MEDIUM AND PROCESS | POLAROID CORPORATION (US) | 1999-03-03 | — | — | EP | claimed |
| US-5759721-A | Holographic medium and process for use thereof | POLAROID CORPORATION (US) | 1998-06-02 | — | — | US | claimed |
| US-5705103-A | Composition for producing chemiluminescent light of controllable duration | JAME FINE CHEMICALS, INC. (US) | 1998-01-06 | — | — | US | claimed |
| WO-1997044714-A1 | HOLOGRAPHIC MEDIUM AND PROCESS | POLAROID CORPORATION (US) | 1997-11-27 | — | — | WO | claimed |
| US-5597517-A | OXALATE ESTER, SOLVENT, ACTIVATOR, FLUORESCER | JAME FINE CHEMICALS, INC. (US) | 1997-01-28 | — | — | US | claimed |
| US-5554480-A | Fluorescent toner processes | XEROX CORPORATION (US) | 1996-09-10 | — | — | US | claimed |
| US-5281367-A | Oxalate ester and solvent, peroxide and solvent, fluorescer, magnesium containing catalyst | JAME FINE CHEMICALS, INC. (US) | 1994-01-25 | — | — | US | claimed |
| US-5241018-A | Shaped articles for air- and spacecraft | UBE INDUSTRIES, LTD. (JP) | 1993-08-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230037660-A1 | METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS | FLT4, FLT1, KDR | APP 1210/4885L3MBTL1 1454/4885ATM 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.